Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles

Fig. 2

Functionalized mesoporous silica nanoparticles (MSN) are taken up by mouse bladder cancer cells. Flow cytometry for MB49 bladder cancer cells exposed to 100 μg/mL PEG–Gd2O3–TRITC–MSN. a MB49-Luc+ cells were used as negative controls for both GFP and TRITC. b MB49-GFP+ cells prior to labeling were 99.8 % GFP+/TRITC. c After labeling, 69.6 % of the cells were found to be GFP+/TRITC+, with a range of levels of rhodamine fluorescence, indicating some cells picked up more MSN particles than others

Back to article page